TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33321008

Group type: EXPERIMENTAL
Intervention: Single-page visual illustration (group I)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual text consent brochure (group II)
Number of subjects: 152
Study: 33308348

Group type: EXPERIMENTAL
Intervention: Liraglutide (n=37)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo (n=40)
Number of subjects: 77
Study: 34637848

Group type: EXPERIMENTAL
Intervention: Intensive community-based intervention (weekly group activities including physical activity and education)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 67
Study: 36401471

Group type: EXPERIMENTAL
Intervention: Xiehuangjiejing (XHJJ) granule, 4.5 g administered 3 times daily
Number of subjects: 180

Group type: COMPARATOR
Intervention: Matched placebo, 4.5 g administered 3 times daily
Number of subjects: 180
Study: 34567439

Group type: COMPARATOR
Intervention: EMDR
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: EMDR 2.0
Number of subjects: 62
Study: 35998864

Group type: EXPERIMENTAL
Intervention: TX Sprouts intervention (gardening, nutrition, and cooking program)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (delayed intervention)
Number of subjects: 16
Study: 33960277

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg daily for three months)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 32380445

Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 57
Study: 35785139

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 140
Study: 32707476

Group type: EXPERIMENTAL
Intervention: Responsible Marijuana Vendor (RMV) training
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no RMV training)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Stores using RMV training
Number of subjects: 150

Group type: COMPARATOR
Intervention: Stores not using RMV training
Number of subjects: 150
Study: 34056699

Group type: EXPERIMENTAL
Intervention: CAB + RPV LA Q8W
Number of subjects: 1045

Group type: COMPARATOR
Intervention: CAB + RPV LA Q4W
Number of subjects: 1045
Study: 32810030

Group type: EXPERIMENTAL
Intervention: One-anastomosis gastric bypass (OAGB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 40
Study: 32962531

Group type: EXPERIMENTAL
Intervention: Elderly patients with cancer
Number of subjects: 123

Group type: COMPARATOR
Intervention: Elderly patients with depression
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Younger patients with cancer
Number of subjects: 123

Group type: COMPARATOR
Intervention: Younger patients with depression
Number of subjects: 123
Study: 33119423

Group type: EXPERIMENTAL
Intervention: lemborexant 5 mg/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: lemborexant 10 mg/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: lemborexant (5 mg/day or 10 mg/day)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: lemborexant
Number of subjects: 9

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9

Group type: COMPARATOR
Intervention: zolpidem
Number of subjects: 9

Group type: COMPARATOR
Intervention: zopiclone
Number of subjects: 9
Study: 33306634

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg effervescent tablets, three tablets per day for two days prior to RNT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine RNT without any intervention (Control group)
Number of subjects: 34
Study: 33025021

Group type: EXPERIMENTAL
Intervention: Community Based Participatory Research (CBPR) intervention for unhealthy alcohol use
Number of subjects: 121
Study: 35791020

Group type: EXPERIMENTAL
Intervention: SMART, a 6-week transdiagnostic CBT for anxiety and depression
Number of subjects: 163

Group type: COMPARATOR
Intervention: Waiting list control (WLC)
Number of subjects: 163
Study: 33706868

Group type: EXPERIMENTAL
Intervention: Platelet reactivity-based strategy (daily measurements of platelet reactivity by Multiplate analyzer)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard of care (P2Y12 receptor inhibitor withdrawn 5 to 7 days before CABG)
Number of subjects: 190
Study: 33355676

Group type: EXPERIMENTAL
Intervention: Burnout measured with the Maslach Burnout Inventory (MBI)
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Depression measured with the Hospital Depression and Anxiety Scale (HADS)
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Anxiety measured with the Hospital Depression and Anxiety Scale (HADS)
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Confirmatory factor analyses
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Exploratory graph analysis combining gaussian graphical model with clustering algorithms
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Key indicators for screening instruments
Number of subjects: 715
Study: 34545997

Group type: EXPERIMENTAL
Intervention: Cilostazol (CLS) 50 mg twice daily plus escitalopram (ESC) 20 mg once daily for six weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo plus escitalopram (ESC) 20 mg once daily for six weeks
Number of subjects: 80
Study: 32085838

Group type: EXPERIMENTAL
Intervention: Cenobamate (YKP3089)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34162993

Group type: EXPERIMENTAL
Intervention: tACS at β frequency (20 Hz) with rPPS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tACS with rPPS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tACS at α frequency (10 Hz) with rPPS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tACS at β frequency (20 Hz) in trough phase with rPPS
Number of subjects: 0
Study: 32481584

Group type: EXPERIMENTAL
Intervention: 5% P-CM
Number of subjects: 0

Group type: COMPARATOR
Intervention: CM
Number of subjects: 0
Study: 34973597

Group type: EXPERIMENTAL
Intervention: Salsalate (1500 mg, twice daily for 4 days)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 33188988

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide
Number of subjects: 92

Group type: COMPARATOR
Intervention: Dexamethasone (Control)
Number of subjects: 92
Study: 32133585

Group type: EXPERIMENTAL
Intervention: L-tyrosine (2.0 g)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 36484666

Group type: EXPERIMENTAL
Intervention: Intraoral scanning
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional impression-taking
Number of subjects: 70
Study: 33690706

Group type: EXPERIMENTAL
Intervention: Model incorporating time‐varying smoking variables
Number of subjects: 126528

Group type: COMPARATOR
Intervention: Pack-years model
Number of subjects: 126528
Study: 36078292

Group type: EXPERIMENTAL
Intervention: Mat Pilates (MP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mat Pilates + Aerobic Exercise (MP+AE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (no exercises)
Number of subjects: 60
Study: 34570072

Group type: EXPERIMENTAL
Intervention: Incentive Spirometry (IS) - 10 deep breaths with a spirometer every 2 hours starting 2 hours after surgery
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no respiratory physiotherapy)
Number of subjects: 84
Study: 35722980

Group type: EXPERIMENTAL
Intervention: Health promotion training provided to elderly individuals, one session a week for three weeks
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 140
Study: 32552857

Group type: EXPERIMENTAL
Intervention: OPTIMIZE intervention
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 2400
Study: 34422261

Group type: EXPERIMENTAL
Intervention: Exercise programme plus food education sessions (EXFE)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Supervised exercise programme (EX)
Number of subjects: 33
Study: 32602301

Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 80
Study: 35738184

Group type: EXPERIMENTAL
Intervention: Microdiscectomy
Number of subjects: 122
Study: 35165477

Group type: EXPERIMENTAL
Intervention: Bioceramic putty repairmen iRoot
Number of subjects: 43

Group type: COMPARATOR
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 43
Study: 34967382

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency therapy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 86
Study: 35056367

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Education intervention
Number of subjects: 24
Study: 35038278

Group type: EXPERIMENTAL
Intervention: Children accompanied by anxious parents
Number of subjects: 160

Group type: COMPARATOR
Intervention: Children accompanied by non-anxious parents
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Children with parents present
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Children with anxious parents
Number of subjects: 160
Study: 34589205

Group type: EXPERIMENTAL
Intervention: Montmorency tart cherries (MC) 30 ml twice daily for 28 days
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo 30 ml twice daily for 28 days
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Montmorency tart cherries (MC)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 33879224

Group type: EXPERIMENTAL
Intervention: IY‐ASLD program
Number of subjects: 70

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 70
Study: 33377701

Group type: EXPERIMENTAL
Intervention: 180W front-firing GreenLight laser PVP
Number of subjects: 61

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 61
Study: 35988825

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000 international units)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 33935265

Group type: EXPERIMENTAL
Intervention: 6-week summer nursing immersion program at a graduate school of nursing
Number of subjects: 3
Study: 32223116

Group type: EXPERIMENTAL
Intervention: Oral anticoagulation plus clopidogrel
Number of subjects: 313

Group type: COMPARATOR
Intervention: Oral anticoagulation alone
Number of subjects: 313
Study: 33291088

Group type: EXPERIMENTAL
Intervention: CA2122
Number of subjects: 244

Group type: COMPARATOR
Intervention: VERO
Number of subjects: 244
Study: 32068870

Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (0.75-6 mg, dosing interval 0.75 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone
Number of subjects: 27
Study: 34211322

Group type: EXPERIMENTAL
Intervention: Resistance band exercise training (EX) 3 days/week
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 35
Study: 35459947

Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid Binding sperm Selection (HABSelect)
Number of subjects: 2752

Group type: COMPARATOR
Intervention: Physiological IntraCytoplasmic Sperm Injection (PICSI)
Number of subjects: 2752
Study: 32749916

Group type: COMPARATOR
Intervention: Ratio 1:2
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ratio 1:1.2
Number of subjects: 44
Study: 32281648

Group type: EXPERIMENTAL
Intervention: P < .05
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: P < .005
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: P < .20
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher threshold (e.g., P < .2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.05 threshold
Number of subjects: 0
Study: 35731517

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus aspirin 100 mg daily
Number of subjects: 6564

Group type: COMPARATOR
Intervention: Placebo plus aspirin 100 mg daily
Number of subjects: 6564
Study: 32950650

Group type: EXPERIMENTAL
Intervention: p factor at baseline
Number of subjects: 0
Study: 32590944

Group type: EXPERIMENTAL
Intervention: Intracoronary prourokinase (10 ml)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (10 ml saline)
Number of subjects: 50
Study: 34255088

Group type: EXPERIMENTAL
Intervention: Training workshop (TRANSLATE) for Implementation Leads
Number of subjects: 9
Study: 34313728

Group type: EXPERIMENTAL
Intervention: Malkia Klabu loyalty programme
Number of subjects: 0
Study: 34647981

Group type: EXPERIMENTAL
Intervention: Rucaparib treatment
Number of subjects: 1052
Study: 32513163

Group type: EXPERIMENTAL
Intervention: GENIE social network self-management intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 36335403

Group type: EXPERIMENTAL
Intervention: Modified muscle sparing technique (SPAIRE) in hip hemiarthroplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard lateral technique in hip hemiarthroplasty
Number of subjects: 0
Study: 34277985

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 35977778

Group type: EXPERIMENTAL
Intervention: Intrathecal hydromorphone (100 μg)
Number of subjects: 126

Group type: COMPARATOR
Intervention: No block (Control)
Number of subjects: 126
Study: 34125700

Group type: EXPERIMENTAL
Intervention: Community-led total sanitation (CLTS) intervention
Number of subjects: 906
Study: 33013880

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: 2 g TXA
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: 4 g TXA
Number of subjects: 149
Study: 34159757

Group type: EXPERIMENTAL
Intervention: Leg fidgeting during prolonged sitting
Number of subjects: 20
Study: 33611573

Group type: EXPERIMENTAL
Intervention: Cancer survivors (breast cancer)
Number of subjects: 14316

Group type: EXPERIMENTAL
Intervention: Cancer survivors (leukemia)
Number of subjects: 14316

Group type: EXPERIMENTAL
Intervention: Cancer survivors (Hodgkin lymphoma)
Number of subjects: 14316

Group type: EXPERIMENTAL
Intervention: Cancer survivors (non-Hodgkin lymphoma)
Number of subjects: 14316

Group type: EXPERIMENTAL
Intervention: Cancer survivors (thyroid cancer)
Number of subjects: 14316

Group type: EXPERIMENTAL
Intervention: Cancer survivors (melanoma)
Number of subjects: 14316

Group type: EXPERIMENTAL
Intervention: Cancer survivors (overall)
Number of subjects: 14316

Group type: COMPARATOR
Intervention: Unexposed women
Number of subjects: 14316
Study: 32164314

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Circuit Training (HIICT)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 54
Study: 35834738

Group type: EXPERIMENTAL
Intervention: Treadmill training with virtual reality
Number of subjects: 31

Group type: COMPARATOR
Intervention: Treadmill training alone
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard of care overground therapy
Number of subjects: 31
Study: 33516712

Group type: EXPERIMENTAL
Intervention: DTA (DiamondTemp Ablation System)
Number of subjects: 482

Group type: COMPARATOR
Intervention: Control (force-sensing RF ablation system)
Number of subjects: 482
Study: 32419536

Group type: EXPERIMENTAL
Intervention: guselkumab
Number of subjects: 126

Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 126

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 126
Study: 34275259

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 12
Study: 33336698

Group type: EXPERIMENTAL
Intervention: DOR/3TC/TDF (Doravirine 100 mg, Lamivudine 300 mg, Tenofovir Disoproxil Fumarate 300 mg)
Number of subjects: 734

Group type: COMPARATOR
Intervention: EFV/FTC/TDF (Efavirenz 600 mg, Emtricitabine 200 mg, Tenofovir Disoproxil Fumarate 300 mg)
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: DOR/3TC/TDF
Number of subjects: 734

Group type: COMPARATOR
Intervention: EFV/FTC/TDF
Number of subjects: 734
Study: 32574384

Group type: EXPERIMENTAL
Intervention: Gender-neutral vaccination
Number of subjects: 8022

Group type: EXPERIMENTAL
Intervention: Girls-only vaccination
Number of subjects: 8022
Study: 36209076

Group type: EXPERIMENTAL
Intervention: Near-peer facilitators
Number of subjects: 365

Group type: COMPARATOR
Intervention: Faculty facilitators
Number of subjects: 365
Study: 33817809

Group type: EXPERIMENTAL
Intervention: Adjunctive phototherapy protocol ('Perio‐1') with root surface debridement (RSD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Root surface debridement (RSD) alone (control sextants)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adjunctive phototherapy protocol ('Perio‐1') with RSD
Number of subjects: 60
Study: 36308120

Group type: EXPERIMENTAL
Intervention: MSICS with cauterization using wetfield bipolar cautery with 4 amperes power (Group 1, n = 75)
Number of subjects: 150

Group type: COMPARATOR
Intervention: No cauterization (Group 2, n = 75)
Number of subjects: 150
Study: 34219679

Group type: EXPERIMENTAL
Intervention: tDCS of the visual cortex (n=7)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: tDCS/rtACS (n=8)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: rtACS alone (n=8)
Number of subjects: 56

Group type: COMPARATOR
Intervention: sham (n=7)
Number of subjects: 56

Group type: COMPARATOR
Intervention: sham (n=9)
Number of subjects: 56

Group type: COMPARATOR
Intervention: sham (n=8)
Number of subjects: 56
Study: 33372070

Group type: EXPERIMENTAL
Intervention: TAU (treatment as usual)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TAU + LMP (lifestyle modification programme)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TAU + LMP + ICTs (information and communication technologies)
Number of subjects: 0
Study: 34767764

Group type: EXPERIMENTAL
Intervention: Tofacitinib (n=72)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo (n=70)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study: 33228744

Group type: EXPERIMENTAL
Intervention: Active psychological treatments for depression (specific treatments not detailed)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Trial participation
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Understanding of trial design
Number of subjects: 58
Study: 35713803

Group type: EXPERIMENTAL
Intervention: High esthetic food
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low esthetic food
Number of subjects: 0
Study: 33640861

Group type: EXPERIMENTAL
Intervention: Zuranolone (30mg)
Number of subjects: 89
Study: 32481364

Group type: EXPERIMENTAL
Intervention: Huangqi Guizhi Wuwu decoction
Number of subjects: 360

Group type: COMPARATOR
Intervention: Huangqi Guizhi Wuwu decoction mimetic agent
Number of subjects: 360
Study: 35664468

Group type: EXPERIMENTAL
Intervention: tDCS active stimulation
Number of subjects: 37

Group type: COMPARATOR
Intervention: tDCS sham stimulation
Number of subjects: 37
Study: 33269819

Group type: EXPERIMENTAL
Intervention: Volume-targeted mechanical ventilation (VG-AC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pressure-controlled mechanical ventilation (PC-AC)
Number of subjects: 20
Study: 34951112

Group type: EXPERIMENTAL
Intervention: PREVENT (standard iBWL + prevention-focused training)
Number of subjects: 95

Group type: COMPARATOR
Intervention: STANDARD (standard iBWL)
Number of subjects: 95

Group type: COMPARATOR
Intervention: PROMOTE (standard iBWL + promotion-focused training)
Number of subjects: 95
Study: 34128447

Group type: EXPERIMENTAL
Intervention: Morning Exercise Training (METP)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Evening Exercise Training (METP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Both Morning and Evening METP
Number of subjects: 36
Study: 32675291

Group type: EXPERIMENTAL
Intervention: WBF-011
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 34193072

Group type: EXPERIMENTAL
Intervention: Thermo Fisher TaqPath™ Combo Kit
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cepheid Xpert® Xpress SARS-CoV-2 assay
Number of subjects: 300
Study: 34619050

Group type: EXPERIMENTAL
Intervention: SSRI + hydroxyzine
Number of subjects: 53

Group type: COMPARATOR
Intervention: SSRI only
Number of subjects: 53
Study: 33929215

Group type: EXPERIMENTAL
Intervention: Random measurements in three-qubit systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random measurements in higher-dimensional two-particle systems
Number of subjects: 0
Study: 35678636

Group type: EXPERIMENTAL
Intervention: Test-negative design (TND)
Number of subjects: 7029

Group type: COMPARATOR
Intervention: Matched case-control design (MCC)
Number of subjects: 7029
Study: 33979232

Group type: EXPERIMENTAL
Intervention: Single-use negative pressure wound therapy (sNPWT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 33543449

Group type: EXPERIMENTAL
Intervention: 3Mix-MP
Number of subjects: 44

Group type: COMPARATOR
Intervention: Calcium Hydroxide
Number of subjects: 44
Study: 36395435

Group type: EXPERIMENTAL
Intervention: Zanubrutinib
Number of subjects: 415

Group type: COMPARATOR
Intervention: Ibrutinib
Number of subjects: 415
Study: 32552523

Group type: EXPERIMENTAL
Intervention: Endovascular Therapeutic hypothermia (ETH) with primary PCI
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (primary PCI only)
Number of subjects: 50
Study: 32459600

Group type: EXPERIMENTAL
Intervention: Acalabrutinib monotherapy
Number of subjects: 310

Group type: COMPARATOR
Intervention: Investigator's choice (Idelalisib plus Rituximab)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Investigator's choice (Bendamustine plus Rituximab)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Idelalisib plus Rituximab
Number of subjects: 310

Group type: COMPARATOR
Intervention: Bendamustine plus Rituximab
Number of subjects: 310
Study: 34367045

Group type: EXPERIMENTAL
Intervention: Enhanced training group
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard training group
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 106
Study: 33183325

Group type: EXPERIMENTAL
Intervention: TPVB group (n = 45)
Number of subjects: 90

Group type: COMPARATOR
Intervention: GA group (n = 45)
Number of subjects: 90
Study: 35953881

Group type: EXPERIMENTAL
Intervention: Nitazoxanide
Number of subjects: 828

Group type: EXPERIMENTAL
Intervention: Sofosbuvir/daclatasvir
Number of subjects: 828

Group type: COMPARATOR
Intervention: Control (standard prevention advice)
Number of subjects: 828